Even Pharma IPO success

 

Theobald Associates is pleased to announce the successful IPO of its client, the Liverpool-based pharmaceutical, Evgen Pharma. In the AIM stock market float the Company raised £7 million via an oversubscribed share placing. The cash raised by the transaction will be used to pursue the clinical development of the novel technology that Evgen has been researching. Further details can be found HERE.